AU2006293814B2 - Method for obtaining human smooth muscular cells and uses thereof - Google Patents

Method for obtaining human smooth muscular cells and uses thereof Download PDF

Info

Publication number
AU2006293814B2
AU2006293814B2 AU2006293814A AU2006293814A AU2006293814B2 AU 2006293814 B2 AU2006293814 B2 AU 2006293814B2 AU 2006293814 A AU2006293814 A AU 2006293814A AU 2006293814 A AU2006293814 A AU 2006293814A AU 2006293814 B2 AU2006293814 B2 AU 2006293814B2
Authority
AU
Australia
Prior art keywords
cells
medium
human
culture
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006293814A
Other languages
English (en)
Other versions
AU2006293814A1 (en
Inventor
Marie-Noelle Lacassagne
Sophie Le Ricousse
Jean-Pierre Marolleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Original Assignee
Assistance Publique Hopitaux de Paris APHP
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, IVS Institut des Vaisseaux et du Sang filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of AU2006293814A1 publication Critical patent/AU2006293814A1/en
Application granted granted Critical
Publication of AU2006293814B2 publication Critical patent/AU2006293814B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
AU2006293814A 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof Ceased AU2006293814B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
FR0509557 2005-09-19
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (2)

Publication Number Publication Date
AU2006293814A1 AU2006293814A1 (en) 2007-03-29
AU2006293814B2 true AU2006293814B2 (en) 2011-09-29

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006293814A Ceased AU2006293814B2 (en) 2005-09-19 2006-09-19 Method for obtaining human smooth muscular cells and uses thereof

Country Status (10)

Country Link
US (1) US20090269310A1 (https=)
EP (1) EP1934333B9 (https=)
JP (1) JP2009508511A (https=)
CN (1) CN101310013B (https=)
AT (1) ATE531791T1 (https=)
AU (1) AU2006293814B2 (https=)
CA (1) CA2622916A1 (https=)
FR (1) FR2890977A1 (https=)
IL (1) IL190289A0 (https=)
WO (1) WO2007034069A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
ES2689932T3 (es) * 2008-11-04 2018-11-16 Inregen Construcciones de armazones de células
US11617768B2 (en) * 2017-12-14 2023-04-04 Innovacell Ag Methods for obtaining muscle derived cells
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
IL286509B1 (en) * 2019-03-22 2026-04-01 Innovacell Gmbh Methods for obtaining induced smooth muscle cells
WO2024143453A1 (ja) * 2022-12-28 2024-07-04 インターステム株式会社 細胞組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Le Ricousse-Roussanne et al (2004) Cardiovascular Research. Vol. 62, pps 176-184 *
Simper etal (2002) Circulation, Vol, 106, pps 1199-1204 *

Also Published As

Publication number Publication date
US20090269310A1 (en) 2009-10-29
FR2890977A1 (fr) 2007-03-23
CN101310013B (zh) 2011-09-07
IL190289A0 (en) 2011-08-01
AU2006293814A1 (en) 2007-03-29
EP1934333B1 (fr) 2011-11-02
EP1934333B9 (fr) 2012-05-02
EP1934333A1 (fr) 2008-06-25
JP2009508511A (ja) 2009-03-05
ATE531791T1 (de) 2011-11-15
CA2622916A1 (fr) 2007-03-29
WO2007034069A1 (fr) 2007-03-29
CN101310013A (zh) 2008-11-19

Similar Documents

Publication Publication Date Title
US7582292B2 (en) Adipose tissue derived stromal cells for the treatment of neurological disorders
Mimeault et al. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies
Torrente et al. Intraarterial injection of muscle-derived CD34+ Sca-1+ stem cells restores dystrophin in mdx mice
Zhang et al. SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction
EP1261694B1 (en) Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
Volonte et al. The modulation of caveolin‐1 expression controls satellite cell activation during muscle repair
US20050169896A1 (en) Bone marrow transplantation for treatment of stroke
Watanabe et al. A human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system
CA2464088A1 (en) Stem cells that transform to beating cardiomyocytes
CA2642564A1 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2013211934B2 (en) Methods and compositions for modulating angiogenesis and vasculogenesis
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
EP3277297A1 (en) Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
AU2006293814B2 (en) Method for obtaining human smooth muscular cells and uses thereof
KR102630220B1 (ko) 유도만능줄기세포-유래 중간엽 줄기세포 전구세포로부터 유래된 엑소좀을 포함하는 신장 질환의 예방 또는 치료용 조성물
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
CN110551688B (zh) 一种诱导体细胞重编程为造血干/祖细胞且促进造血干/祖细胞体外扩增的组合物及其应用
Kim et al. Intracellular transduction of TAT-Hsp27 fusion protein enhancing cell survival and regeneration capacity of cardiac stem cells in acute myocardial infarction
JP2009508511A5 (https=)
Hattori et al. Intracranial transplantation of monocyte‐derived multipotential cells enhances recovery after ischemic stroke in rats
Le Ricousse-Roussanne et al. Ex vivo generation of mature and functional human smooth muscle cells differentiated from skeletal myoblasts
WO2001048150A1 (en) Cells capable of differentiating into heart muscle cells
Zhao et al. Cardiac commitment driven by MyoD expression in pericardial stem cells
WO2007047963A2 (en) Use of bone-marrow derived stem cells to treat ischemia
US20190382728A1 (en) Menstrual Blood Derived Angiogenesis Stimulatory Cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired